Send me a link:

*Text messaging rates may apply.

 Dow Down0.72% Nasdaq Down0.50%

More On ONCY

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Oncolytics Biotech Inc. (ONCY)

-NasdaqCM
1.40 Down 0.03(2.10%) Jul 25, 3:59PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.3
Mean Recommendation (last week):1.6
Change:-0.3

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:6.29
Median Target:6.44
High Target:8.00
Low Target:5.00
No. of Brokers:5

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Aug 30, 2012Stifel NicolausInitiated Buy
May 17, 2011OppenheimerInitiated Perform
Apr 13, 2011WedbushInitiated Outperform
Dec 22, 2009Rodman & RenshawDowngradeMkt OutperformMkt Perform
Oct 16, 2008Merriman Curhan FordInitiated Buy
Jan 15, 2008Rodman & RenshawInitiated Mkt Outperform
Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy3334
Buy1444
Hold1111
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.